Worth a shot.

The FDA’s eloquent take on hydroxychloroquine, serving as reasoning enough for its emergency approval on Saturday for its use as treatment of COVID-19, the most commonly-cited data being these 20 French patients who achieved a decrease in viral load by day 6 particularly when hydroxychloroquine was used with azithromycin. | Rowland, Washington Post 2020